Work

Public Comment at the COVID vaccine FDA Advisory Committee Meeting February 26, 2021

Year: 2021

Type: other

Abstract: Public comments on COVID-19 vaccine side effect surveillance at the US Food and Drug Administration (FDA) Advisory Committee on February 26, 2021. The Janssen (Johnson & Johnson) vaccine was discussed at this meeting. We declare no conflicts of interest.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/ay70-j208

Authors: Lazard, Allison, Brownstein, John S., Dasgupta, Nabarun

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3206125035

Cites:

Cited by:

Related to: 10